The role of Beta-adrenergic receptor blockers in Alzheimer's disease: potential genetic and cellular signaling mechanisms (Q38108100)

29 August 2017

title

The role of Beta-adrenergic receptor blockers in Alzheimer's disease: potential genetic and cellular signaling mechanisms (English)

1 reference

29 August 2017

0 references

Khanh vinh quoc Lương

series ordinal

1

1 reference

29 August 2017

Lan Thi Hoàng Nguyen

series ordinal

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

20 May 2013

1 reference

American Journal of Alzheimer's Disease & Other Dementias

29 August 2017

published in

1 reference

29 August 2017

volume

28

1 reference

29 August 2017

issue

5

1 reference

29 August 2017

page(s)

427-439

1 reference

Distribution of the beta-2 adrenergic receptor messenger RNA in the rat brain by in situ hybridization histochemistry: effects of chronic reserpine treatment

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Binding of amyloid beta peptide to beta2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Amyloid beta peptide-(1-42) induces internalization and degradation of beta2 adrenergic receptors in prefrontal cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Changes in beta-adrenergic receptor subtypes in Alzheimer-type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Agonistic autoantibodies to the α(1) -adrenergic receptor and the β(2) -adrenergic receptor in Alzheimer's and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Norepinephrine differentially modulates the innate inflammatory response provoked by amyloid-β peptide via action at β-adrenoceptors and activation of cAMP/PKA pathway in human THP-1 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Reduced tissue levels of noradrenaline are associated with behavioral phenotypes of the TgCRND8 mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Norepinephrine promotes microglia to uptake and degrade amyloid beta peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Memory loss caused by beta-amyloid protein is rescued by a beta(3)-adrenoceptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Beta2 adrenergic agonist, clenbuterol, enhances working memory performance in aging animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

The influence of beta-blockers on delayed memory function in people with cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Beta-adrenoceptor density and subtype distribution in cerebellum and hippocampus from patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Activation of beta2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Blocking beta2-adrenergic receptor attenuates acute stress-induced amyloid beta peptides production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Effects of cardiovascular medications on rate of functional decline in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence-accelerated mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Neuroprotective effect of carvedilol, an adrenergic antagonist against colchicine induced cognitive impairment and oxidative damage in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Neuroprotective effect of carvedilol against aluminium induced toxicity: possible behavioral and biochemical alterations in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Carvedilol as a potential novel agent for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Influence and interactions of cathepsin D, HLA-DRB1 and APOE on cognitive abilities in an older non-demented population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Effect of propranolol and IFN-beta on the induction of MHC class II expression and cytokine production by IFN-gamma IN THP-1 human monocytic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

The effect of beta-blockers on the adaptive immune system in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Angiotensin II immunohistochemistry of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Angiotensin synthesis in the brain and increased turnover in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Angiotensin Converting Enzyme in Alzheimer's Disease: Increased Activity in Caudate Nucleus and Cortical Areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Renin inhibitor aliskiren exerts neuroprotection against amyloid beta-peptide toxicity in rat cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Alzheimer disease risk and genetic variation in ACE: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

ACE gene is associated with Alzheimer's disease and atrophy of hippocampus and amygdala.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Beta-adrenergic receptors and angiotensinogen gene expression in mouse hepatoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Endothelial renin-angiotensin pathway. Adrenergic regulation of angiotensin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Vascular renin-angiotensin system and neurotransmission in hypertensive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

The dementia of cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Proteotoxicity and cardiac dysfunction--Alzheimer's disease of the heart?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Open-heart surgery increases cerebrospinal fluid levels of Alzheimer-associated amyloid β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Carvedilol inhibits basal and stimulated ACE production in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Propranolol for severe hemangiomas of infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Propranolol for severe infantile hemangiomas: follow-up report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Novel systemic markers for patients with Alzheimer disease? - a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Interaction between poly(ADP-ribose) polymerase 1 and interleukin 1A genes is associated with Alzheimer's disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Evaluation of the poly(ADP-ribose) polymerase-1 gene variants in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Ketamine-induced ventricular structural, sympathetic and electrophysiological remodelling: pathological consequences and protective effects of metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Increased poly(ADP-ribosyl)ation in skeletal muscle tissue of pediatric patients with severe burn injury: prevention by propranolol treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

beta-Adrenoceptor blockers protect against staurosporine-induced apoptosis in SH-SY5Y neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

The nonselective beta-blocker carvedilol suppresses apoptosis in human cardiac tissue: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

The effect of carvedilol on enhanced ADP-ribosylation and red blood cell membrane damage caused by free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Metipranolol blunts nitric oxide-induced lipid peroxidation and death of retinal photoreceptors: a comparison with other anti-glaucoma drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Vascular endothelial growth factor gene variability is associated with increased risk for AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Association between promoter polymorphisms of vascular endothelial growth factor gene and sporadic Alzheimer's disease among Northern Chinese Han.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

-1154G/A and -2578C/A polymorphisms of the vascular endothelial growth factor gene in Tunisian Alzheimer patients in relation to beta-amyloid (1-42) and total tau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Cancer linked to Alzheimer disease but not vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Beta-adrenergic receptor regulation of growth factor protein levels in human choroidal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Effects of propranolol in combination with radiation on apoptosis and survival of gastric cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Antiangiogenic effects of β2 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Carvedilol modulates the expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in a rat model of volume-overload heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Activation of NADPH oxidase in Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

NOX activity is increased in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

NADPH-oxidase activation and cognition in Alzheimer disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Nebivolol improves insulin sensitivity in the TGR(Ren2)27 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Protective effect of carvedilol on daunorubicin-induced cardiotoxicity and nephrotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Celiprolol Activates eNOS Through the PI3K-Akt Pathway and Inhibits VCAM-1 Via NF-κB Induced by Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Matrix metalloproteinases and diseases of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Increased matrix metalloproteinase 9 activity in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

The interaction of amyloid β and the receptor for advanced glycation endproducts induces matrix metalloproteinase-2 expression in brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Analysis of functional polymorphisms of metalloproteinase genes in persons with vascular dementia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Matrix metalloproteinase 3 haplotypes and plasma amyloid beta levels: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Impact of the matrix metalloproteinase MMP-3 on dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Matrix metalloprotease-9 inhibition improves amyloid beta-mediated cognitive impairment and neurotoxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

SAR150640, a selective beta3-adrenoceptor agonist, prevents human myometrial remodelling and activation of matrix metalloproteinase in an in vitro model of chorioamnionitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

MAP kinase signaling cascades and gene expression in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Activation of MKK6, an upstream activator of p38, in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

p38 kinase is activated in the Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Tau phosphorylation in Alzheimer's disease: potential involvement of an APP-MAP kinase complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Propranolol induces regression of hemangioma cells through HIF-1α-mediated inhibition of VEGF-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Prostaglandins and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Detrimental effects of arachidonic acid and its metabolites in cellular and mouse models of Alzheimer's disease: structural insight

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Amyloid-β induces cyclooxygenase-2 and PGE2 release in human astrocytes in NF-κ B dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Cyclooxygenase (COX)-2 and COX-1 Potentiate β-Amyloid Peptide Generation through Mechanisms That Involve γ-Secretase Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Association Study of Interferon-γ, Cytosolic Phospholipase A2, and Cyclooxygenase-2 Gene Polymorphisms in Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Elevated oxidative stress in models of normal brain aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Free radical injury in skin cultured fibroblasts from Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Cardiac reactive oxygen species after traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

D-propranolol attenuates lysosomal iron accumulation and oxidative injury in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

A Requirement for the Intercellular Messenger Nitric Oxide in Long-Term Potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Nitric oxide and hippocampal synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Endothelial nitric oxide modulates expression and processing of amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Prolonged nitric oxide treatment induces tau aggregation in SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Decrease of TGF-beta1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Decreased eNOS protein expression in involuting and propranolol-treated hemangiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

The spectrum of behavioral changes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Polymorphism in genes involved in adrenergic signaling associated with Alzheimer's.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer's disease susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

APOE ε4 increases risk for dementia in pure synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Nonlinear mixed effects model analysis of the pharmacokinetics of metoprolol in routinely treated Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Evaluation of effects of polymorphism for metabolic enzymes on pharmacokinetics of carvedilol by population pharmacokinetic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Influence of CYP2D6*10 on the pharmacokinetics of metoprolol in healthy Korean volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

Cellular localization of messenger RNA for beta-1 and beta-2 adrenergic receptors in rat brain: An in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317513488924

21 January 2018

Identifiers

DOI

10.1177/1533317513488924

1 reference

29 August 2017

1 reference